| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | RGD:1344538 | 6480464 | Metribolone results in decreased expression of MAPRE2 mRNA | CTD | PMID:17010675 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAPRE2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1344538 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAPRE2 mRNA | CTD | PMID:22903824 |
| 2,3-dimethoxynaphthalene-1,4-dione | increases expression | ISO | RGD:1344538 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of MAPRE2 mRNA | CTD | PMID:19031421 |
| 2-methylcholine | affects expression | ISO | RGD:1344538 | 6480464 | beta-methylcholine affects the expression of MAPRE2 mRNA | CTD | PMID:21179406 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MAPRE2 mRNA | CTD | PMID:20188158 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of MAPRE2 mRNA | CTD | PMID:18648102 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1344538 | 6480464 | Benzo(a)pyrene results in decreased expression of MAPRE2 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | | 6480464 | Benzo(a)pyrene results in increased expression of MAPRE2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] affects the expression of MAPRE2 mRNA | CTD | PMID:21715664 |
| bilirubin | decreases expression | ISO | RGD:1344538 | 6480464 | Bilirubin results in decreased expression of MAPRE2 mRNA | CTD | PMID:20196124 |
| cyclosporin A | decreases expression | ISO | RGD:1344538 | 6480464 | Cyclosporine results in decreased expression of MAPRE2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | | 6480464 | Cyclosporine results in decreased expression of MAPRE2 mRNA | CTD | PMID:19770486 |
| ibuprofen | affects expression | ISO | RGD:1344538 | 6480464 | Ibuprofen affects the expression of MAPRE2 mRNA | CTD | PMID:17070997 |
| methylazoxymethanol | increases expression | ISO | | 6480464 | methylazoxymethanol results in increased expression of MAPRE2 mRNA | CTD | PMID:17107856 |
| paracetamol | affects expression | ISO | | 6480464 | Acetaminophen affects the expression of MAPRE2 mRNA | CTD | PMID:17562736 |
| pirinixic acid | decreases expression | ISO | | 6480464 | pirinixic acid results in decreased expression of MAPRE2 mRNA | CTD | PMID:20813756 PMID:18445702 |
| pirinixic acid | decreases expression | ISO | | 6480464 | pirinixic acid results in decreased expression of MAPRE2 mRNA | CTD | PMID:18445702 PMID:20813756 |
| pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of MAPRE2 mRNA | CTD | PMID:17426115 |
| succimer | multiple interactions | ISO | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPRE2 mRNA | CTD | PMID:21641980 |
| tetrachloroethene | increases expression | ISO | RGD:1344538 | 6480464 | Tetrachloroethylene results in increased expression of MAPRE2 mRNA | CTD | PMID:19031421 |
| trimellitic anhydride | increases expression | ISO | | 6480464 | trimellitic anhydride results in increased expression of MAPRE2 mRNA | CTD | PMID:19042947 |